A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
Authors
Alexandre Nicolas,
Gérémy SannierMathieu Dubé,
Manon Nayrac,
Mark Painter,
Rishi Goel,
Mélanie Laporte,
Halima Medjahed,
Justine Williams,
Nathalie Brassard,
Julia Nießl,
Laurie Gokool,
Chantal Morrisseau,
Pascale Arlotto,
Cécile Tremblay,
Valérie Martel-Laferrière,
Andrés Finzi,
Allison Greenplate,
E. Wherry,
Daniel Kaufmann,
Julia Niessl +19 authors
,
Valérie Martel‐Laferrière Tip Tip